Chapter 9
Should Prognostic Variables be Used to Direct Patient Management in the Acute Setting?
Mario D'Amico MD,
Juan Carlos García-Pagán MD, PhD,
Mario D'Amico MD
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Spain
Search for more papers by this authorJuan Carlos García-Pagán MD, PhD
Consultant
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Spain
Search for more papers by this authorMario D'Amico MD,
Juan Carlos García-Pagán MD, PhD,
Mario D'Amico MD
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Spain
Search for more papers by this authorJuan Carlos García-Pagán MD, PhD
Consultant
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Spain
Search for more papers by this authorBook Editor(s):Roberto de Franchis MD, AGAF,
Roberto de Franchis MD, AGAF
Professor of Gastroenterology Head
Department of Medical Sciences, University of Milan, and Gastroenterology 3 Unit, IRCCS Ca' Granda Ospedale Maggiore Policlinico Mangiagalli and Regina Elena Foundation, Milan, Italy
Search for more papers by this authorFirst published: 17 November 2010
Summary
This chapter contains sections titled:
-
Introduction
-
Prognostic factors in acute variceal bleeding
-
Possible strategies for patients with high-risk treatment failure
-
Conclusions
-
References
References
- de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. JHepatol 43: 167–76.
- Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W (2007) Prevention and management of gastro-esophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46: 922–38.
- D'Amico G, de Franchis R (2003) Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38: 599–612.
- Bañares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology 35: 609–15.
- Ready JB, Robertson AD, Goff JS, Rector WG, Jr (1991) Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology 100: 1403–10.
- Gatta A, Merkel C, Amodio P, et al. (1994) Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol 89: 1528–36.
- Ben Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK (1999) A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 31: 443–50.
- Moitinho E, Escorsell A, Bandi JC, et al. (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117: 626–31.
- Villanueva C, Ortiz J, Minana J, et al. (2001) Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121: 110–17.
- Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40: 793–801.
- Lo GH, Chen WC, Chen MH, et al. (2004) The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy. Gastrointest Endosc 60: 714–20.
- Park DK, Um SH, Lee JW, et al. (2004) Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices. J Gastroenterol Hepatol 19: 1042–51.
- Carbonell N, Pauwels A, Serfaty L, et al. (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40: 652–9.
- Lecleire S, Di FF, Merle V, et al. (2005) Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol 39: 321–7.
- Thomopoulos K, Theocharis G, Mimidis K, et al. (2006) Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 38: 899–904.
- Abraldes JG, Villanueva C, Bañares R, et al. (2008) Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. JHepatol 48: 229–36.
- Bambha K, Kim WR, Kremers WK, et al. (2004) Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 4: 1798–804.
- Krige JE, Kotze UK, Distiller G, Shaw JM, Bornman PC (2009) Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg 33: 2127–35.
- Hsu YC, Chung CS, Tseng CH, et al. (2009) Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol 24: 1294–9.
- Augustin S, Muntaner L, Altamirano JT, et al. (2009) Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol 7: 1347–54.
- D'Amico G, Pagliaro L, Bosch J. (1999) Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19: 475–505.
- Cardenas A, Gines P, Uriz J, et al. (2001) Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34: 671–6.
- Cirera I, Feu F, Luca A, et al. (1995) Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology 22: 106–11.
- Moitinho E, Planas R, Bañares R, et al. (2001) Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol 35: 712–18.
- Palazon JM, Such J, Sanchez-Paya J, et al. (2006) A comparison of two different dosages of somatostatin combined with sclerotherapy for the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Rev Esp Enferm Dig 98: 249–54.
- Villanueva C, Planella M, Aracil C, et al. (2005) Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Am J Gastroenterol 100: 624–630.
- Bosch J, Thabut D, Bendtsen F, et al. (2004) Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127: 1123–1130.
- Bosch J, Thabut D, Albillos A, et al. (2008) Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology 47: 1604–1614.
- Escorsell A, Bañares R, García-Pagán JC, et al. (2002) TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35: 385–392.
- Khan S, Tudur SC, Williamson P, Sutton R. (2006) Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev (4): CD000553.
- Bureau C, García-Pagán JC, Pomier-Layrargues G, et al. (2004) A randomized study comparing the use of polytetrafluoroethylene (PTFE) covered stents and non-covered stents for TIPS: long term results. Hepatology 40(Suppl 1): 186A.
- García-Pagán JC, Caca K, Bureau C, et al. (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362: 2370–9.
